(NYSE:JNJ) at the start of May recalled 43 over-the-counter medicines made for infants and children -- including liquid versions of Tylenol, Motrin, Zyrtec and Benadryl. JNJ shares are down more than 9% and thanks to the recall this dip may be a buying opportunity.
Aucun commentaire:
Enregistrer un commentaire